Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 21.98% | 21.98% | -90.20% | -90.20% | |
| Total Depreciation and Amortization | 11.76% | 11.76% | 14.00% | 14.00% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 244.03% | 244.03% | -67.81% | -67.81% | |
| Change in Net Operating Assets | 225.88% | 225.88% | 89.85% | 89.85% | |
| Cash from Operations | 494.88% | 494.88% | 205.41% | 205.41% | |
| Capital Expenditure | -269.03% | -269.03% | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -2.15% | -2.15% | -113.63% | -113.63% | |
| Cash from Investing | -24.87% | -24.87% | -113.79% | -113.79% | |
| Total Debt Issued | 31.65% | 31.65% | -66.24% | -66.24% | |
| Total Debt Repaid | -312.36% | -312.36% | -- | -- | |
| Issuance of Common Stock | -- | -- | -98.46% | -98.46% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -1,402.11% | -1,402.11% | 106.06% | 106.06% | |
| Foreign Exchange rate Adjustments | 123.43% | 123.43% | -76.79% | -76.79% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -73.00% | -73.00% | -114.91% | -114.91% | |